Business
Announcement on Voluntary Disclosure of Nadroparin Calcium Injection Passing Consistency Evaluation of Quality and Efficacy of Generic Drugs
Announcement on Voluntary Disclosure of Nadroparin Calcium Injection Passing Consistency Evaluation of Quality and Efficacy of Generic Drugs
About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Announcement on Voluntary Disclosure of Nadroparin Calcium Injection Passing Consistency Evaluation of Quality and Efficacy of Generic DrugsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment